<DOC>
	<DOCNO>NCT01080872</DOCNO>
	<brief_summary>The aim trial ass coronary artery reactivity use adenosine-induced coronary flow reserve ( CFR ) transthoracic echocardiography patient Bio-active stent ( BAS ) Everolimus-eluting stent ( EES ) distal original culprit lesion 6-8 month .</brief_summary>
	<brief_title>Coronary Flow Reserve Patients With Bio-active Stent Everolimus-eluting Stent Implanted Acute Coronary Syndrome</brief_title>
	<detailed_description>Objective : The aim trial ass coronary artery reactivity use adenosine-induced coronary flow reserve ( CFR ) transthoracic echocardiography patient Bio-active stent ( BAS ) Everolimus-eluting stent ( EES ) distal original culprit lesion 6-8 month . Design : BASE-CFR substudy large randomized multicenter BASE-ACS trial compare bio-active Titan stent everolimus-eluting stent patient acute coronary syndrome . CFR assessment perform 6-8 month stent implantation time OCT assessment . In-stent restenosis rule use OCT. Primary endpoint : CFR 6-8 month stent implantation . Secondary endpoint : Coronary flow velocity baseline adenosine-induced hyperemia 6-8 month stent implantation.. Association CFR unendotheliazed stent strut stent malapposition . Enrollment : 40 patient ( 20 receive BAS 20 receive EES ) . Clinical site : Satakunta Central Hospital , Finland Turku University Hospital , Finland</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>The patient enrol BASEACS trial . Treated culprit lesion proximal middle LAD Patient patient 's legal representative inform nature study provide write informed consent approve Institutional Ethics Committee respective clinical site Diabetes mellitus Treated stent position LAD proximal middle . EF &lt; 30 % Bifurcation lesions Renal impairment ( creatinine &gt; 120 mmol/L ) No suitable anatomy OCT scan CFR measurement</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>acute coronary syndrome</keyword>
	<keyword>coronary flow reserve</keyword>
	<keyword>OCT</keyword>
	<keyword>heal</keyword>
	<keyword>drug elute stent</keyword>
</DOC>